Injectable disease-modifying therapy for relapsing-remitting multiple sclerosis: a review of adherence data

Long-term adherence to disease-modifying therapy in relapsing-remitting multiple sclerosis (RRMS) is associated with improved patient outcomes, including a reduced risk of relapse and a better preserved quality of life. However, the unpredictable nature of the disease--even when it is being treated-...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of neuroscience nursing Vol. 42; no. 5 Suppl; p. S5
Main Authors Caon, Christina, Saunders, Carol, Smrtka, Jennifer, Baxter, Nancy, Shoemaker, Jennifer
Format Journal Article
LanguageEnglish
Published United States 01.10.2010
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Long-term adherence to disease-modifying therapy in relapsing-remitting multiple sclerosis (RRMS) is associated with improved patient outcomes, including a reduced risk of relapse and a better preserved quality of life. However, the unpredictable nature of the disease--even when it is being treated--may make it difficult to convince patients of the importance of treatment adherence. A number of studies have attempted to pinpoint factors that affect adherence. Nursing interventions that address some of these factors may improve adherence and, thus, the disease course for a variety of RRMS patients. This article summarizes literature that approximates the prevalence and impact of nonadherence and reviews factors identified in clinical trials that affect adherence. Nursing interventions that can improve adherence, including telephone counseling and motivational interview techniques, are also addressed.
ISSN:0888-0395
DOI:10.1097/JNN.0b013e3181ee1240